“AAAH’s major investment in Cape Town will boost investment into the Western Cape health-tech industry by approximately R1billion and create jobs”
Note to editors: Premier Alan Winde today accompanied President Cyril Ramaphosa to the launch of the coalition to Accelerate Africa’s Access to Advanced Healthcare (AAAH) coalition and the official opening of the NANTSA vaccine manufacturing campus in Cape Town.
Today marked the launch of Africa’s Access to Advanced Healthcare (AAAH) coalition with NANTSA which aims to manufacture a billion doses of the COVID-19 vaccine by 2025. The coalition also aims to establish innovative manufacturing techniques to provide new treatments for life-threatening diseases including cancer, COVID-19, Tuberculosis and HIV/AIDs.
I had the opportunity to join President Ramaphosa in welcoming this launch today, led by Dr Patrick Soon-Shiong, which includes biotechnology and pharmaceutical companies, various levels of government, NGOs, and academia – to bolster this manufacturing sector.
The fact that this investment is happening right here in Cape Town is great news for our economy, which already has a growing health technology sector and is well-positioned to grow over the next decade. This is critical as we focus on the second pandemic of unemployment, by creating the jobs we need to recover.
It is also inspiring that Cape Town, will play a major role in ensuring that access to life-saving vaccines is achieved across the African continent. Throughout our vaccination programme, we have emphasized that access and equity are non-negotiables to a successful programme because every life matters and no person should be left behind. This should be the case within South Africa, but also across the world.
I am also excited about what this means for our established health technology sector in the province. This sector generated nearly a billion Rand (R912.3 million) in medical devices and pharmaceutical exports in 2019. Between 2015 to 2019, pharmaceutical exports saw a year-on-year increase.
Nationally, the pharmaceutical and medical devices markets were at an estimated R62.7 billion and R19.7 billion respectively in 2020 and were expected to grow to R90.4 billion and R29.6 billion respectively by 2025. If we leverage this clear competitive advantage, we can become global leaders in this space and ensure, that right here at the southern tip of Africa, we play a leading role in the fight against the major health challenges of our time.
In supporting NANTSA, a division of NANTWorks, we, together with Wesgro and the City of Cape Town, have been assisting since 2020, including through the facilitation of site visits and provision of technical details on properties being considered for the campus. This has also included the streamlining of property planning and approval processes.
The Western Cape Government has also supported businesses in the biologics, pharmaceutical and vaccine space more generally by partnering with Wesgro, the City of Cape Town’s Economic Investment unit and the Department of Science and Innovation since 2011 to support growth.
In the last two years alone, we have supported the following initiatives:
We have also supported the broader health tech industry in the Western Cape by:
We know that we need to roll out the red carpet for investors and make doing business as easy as possible in our province. We can accelerate economic growth and create jobs if we do so. This is our number one priority.
I want to especially thank and recognise Dr Soon-Shiong today for his pioneering contribution to our region. Our investment teams stand ready to assist you as you execute this amazing project so that we not only save lives but also create jobs, in our country and on our continent.